Targeting uPA-uPAR interaction to improve intestinal epithelial barrier integrity in inflammatory bowel disease - eBioMedicine

Lancet子刊丨IBD治疗新方向？uPA-uPAR有效调控肠黏膜屏障功能，提供抗炎新策略- 知乎

IJERPH, Free Full-Text

Frontiers Low-dose ganciclovir ameliorates dextran sulfate sodium-induced ulcerative colitis through inhibiting macrophage STING activation in mice

uPAR Antibody AF807 from R&D Systems, a Bio-Techne Brand

PDF) Urokinase-type plasminogen activator receptor (uPAR) as a therapeutic target in cancer

PDF) Elevated PLAUR is observed in the airway epithelium of asthma patients and blocking improves barrier integrity

TRIM40 is a pathogenic driver of inflammatory bowel disease subverting intestinal barrier integrity. - Abstract - Europe PMC

Evaluation of Intestinal Epithelial Barrier Function in Inflammatory Bowel Diseases Using Murine Intestinal Organoids. - Abstract - Europe PMC

Urokinase-type plasminogen activator receptor (uPAR) as a therapeutic target in cancer, Journal of Translational Medicine

Mechanisms of Intestinal Epithelial Barrier Dysfunction by Adherent-Invasive Escherichia coli - ScienceDirect

Urokinase-type plasminogen activator blockade ameliorates experimental colitis in mice

Full article: Beta-carotene regulates the biological activity of EGF in IEC6 cells by alleviating the inflammatory process